cytidine monophosphate has been researched along with Vitreoretinopathy, Proliferative in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldern, KA; Beadle, JR; Cheng, L; Conner, L; Freeman, WR; Hartmann, K; Hostetler, KY; Kim, JS; Kozak, I; Trahan, J; Valiaeva, N | 1 |
1 other study(ies) available for cytidine monophosphate and Vitreoretinopathy, Proliferative
| Article | Year |
|---|---|
A novel cytarabine crystalline lipid prodrug: hexadecyloxypropyl cytarabine 3',5'-cyclic monophosphate for proliferative vitreoretinopathy.
Topics: Animals; Antimetabolites, Antineoplastic; Arabinonucleotides; Cell Line; Cell Survival; Cytidine Monophosphate; Delayed-Action Preparations; Diffusion Chambers, Culture; Electroretinography; Humans; Intravitreal Injections; Kinetics; Ophthalmoscopy; Prodrugs; Rabbits; Rats; Retina; Retinal Pigment Epithelium; Solubility; Vitreoretinopathy, Proliferative; Vitreous Body | 2012 |